Cargando…

Clinical and histopathological features of myositis in systemic lupus erythematosus

OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort da...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiniakou, Eleni, Goldman, Daniel, Corse, Andrea, Mammen, Andrew, Petri, Michelle A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966527/
https://www.ncbi.nlm.nih.gov/pubmed/35351810
http://dx.doi.org/10.1136/lupus-2021-000635
_version_ 1784678663372931072
author Tiniakou, Eleni
Goldman, Daniel
Corse, Andrea
Mammen, Andrew
Petri, Michelle A
author_facet Tiniakou, Eleni
Goldman, Daniel
Corse, Andrea
Mammen, Andrew
Petri, Michelle A
author_sort Tiniakou, Eleni
collection PubMed
description OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort database from May 1987 to June 2016. Subjects with elevated creatine kinase along with evidence of muscle oedema on MRI, myopathic electromyography and/or myopathic muscle biopsy features were defined as having SLE myopathy. Demographic, serological and clinical features were compared between patients with SLE with and without myopathy. Muscle biopsies were histologically classified as polymyositis, dermatomyositis, necrotising myopathy or non-specific myositis. RESULTS: From among 2437 patients with SLE, 179 (7.3%) had myopathy. African American patients were more likely to develop myositis than Caucasian patients (p<0.0001). Compared with those without myopathy, patients with SLE myopathy were more likely to have malar rash (OR 1.67, 1.22–2.29), photosensitivity (OR 1.43, 1.04–1.96), arthritis (OR 1.81, 1.21–2.69), pleurisy (OR 1.77, 1.3–2.42), pericarditis (OR 1.49, 1.06–2.08), acute confusional state (OR 2.07, 1.09–3.94), lymphopaenia (OR 1.64, 1.2–2.24), anti-double-stranded DNA antibodies (OR 1.52, 1.09–2.13), lupus anticoagulant (OR 1.42, 1–2), cognitive impairment (OR 1.87, 1.12–3.13), cataract (OR 1.5, 1.04–2.18), pulmonary hypertension (OR 1.98, 1.13–3.47), pleural fibrosis (OR 2.01, 1.27–3.18), premature gonadal failure (OR 1.9, 1.05–3.43), diabetes (OR 1.92, 1.22–3.02) or hypertension (OR 1.45, 1.06–2). Among 16 muscle biopsies available for review, the most common histological classifications were necrotising myositis (50%) and dermatomyositis (38%). CONCLUSIONS: Patients with SLE myopathy have a higher prevalence of numerous SLE disease manifestations. Necrotising myopathy and dermatomyositis are the most prevalent histopathological features in SLE myopathy.
format Online
Article
Text
id pubmed-8966527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-89665272022-04-19 Clinical and histopathological features of myositis in systemic lupus erythematosus Tiniakou, Eleni Goldman, Daniel Corse, Andrea Mammen, Andrew Petri, Michelle A Lupus Sci Med Epidemiology and Outcomes OBJECTIVE: The objectives of this study were to compare the clinical features of patients with SLE with and without myopathy and to describe the muscle biopsy features of patients with SLE myopathy. METHODS: This nested case–control study included all subjects enrolled in the Hopkins Lupus Cohort database from May 1987 to June 2016. Subjects with elevated creatine kinase along with evidence of muscle oedema on MRI, myopathic electromyography and/or myopathic muscle biopsy features were defined as having SLE myopathy. Demographic, serological and clinical features were compared between patients with SLE with and without myopathy. Muscle biopsies were histologically classified as polymyositis, dermatomyositis, necrotising myopathy or non-specific myositis. RESULTS: From among 2437 patients with SLE, 179 (7.3%) had myopathy. African American patients were more likely to develop myositis than Caucasian patients (p<0.0001). Compared with those without myopathy, patients with SLE myopathy were more likely to have malar rash (OR 1.67, 1.22–2.29), photosensitivity (OR 1.43, 1.04–1.96), arthritis (OR 1.81, 1.21–2.69), pleurisy (OR 1.77, 1.3–2.42), pericarditis (OR 1.49, 1.06–2.08), acute confusional state (OR 2.07, 1.09–3.94), lymphopaenia (OR 1.64, 1.2–2.24), anti-double-stranded DNA antibodies (OR 1.52, 1.09–2.13), lupus anticoagulant (OR 1.42, 1–2), cognitive impairment (OR 1.87, 1.12–3.13), cataract (OR 1.5, 1.04–2.18), pulmonary hypertension (OR 1.98, 1.13–3.47), pleural fibrosis (OR 2.01, 1.27–3.18), premature gonadal failure (OR 1.9, 1.05–3.43), diabetes (OR 1.92, 1.22–3.02) or hypertension (OR 1.45, 1.06–2). Among 16 muscle biopsies available for review, the most common histological classifications were necrotising myositis (50%) and dermatomyositis (38%). CONCLUSIONS: Patients with SLE myopathy have a higher prevalence of numerous SLE disease manifestations. Necrotising myopathy and dermatomyositis are the most prevalent histopathological features in SLE myopathy. BMJ Publishing Group 2022-03-29 /pmc/articles/PMC8966527/ /pubmed/35351810 http://dx.doi.org/10.1136/lupus-2021-000635 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology and Outcomes
Tiniakou, Eleni
Goldman, Daniel
Corse, Andrea
Mammen, Andrew
Petri, Michelle A
Clinical and histopathological features of myositis in systemic lupus erythematosus
title Clinical and histopathological features of myositis in systemic lupus erythematosus
title_full Clinical and histopathological features of myositis in systemic lupus erythematosus
title_fullStr Clinical and histopathological features of myositis in systemic lupus erythematosus
title_full_unstemmed Clinical and histopathological features of myositis in systemic lupus erythematosus
title_short Clinical and histopathological features of myositis in systemic lupus erythematosus
title_sort clinical and histopathological features of myositis in systemic lupus erythematosus
topic Epidemiology and Outcomes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966527/
https://www.ncbi.nlm.nih.gov/pubmed/35351810
http://dx.doi.org/10.1136/lupus-2021-000635
work_keys_str_mv AT tiniakoueleni clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus
AT goldmandaniel clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus
AT corseandrea clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus
AT mammenandrew clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus
AT petrimichellea clinicalandhistopathologicalfeaturesofmyositisinsystemiclupuserythematosus